Infectious Diseases Society of America Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa)

Epidemiology of β-Lactamase-Producing Pathogens

(2020) Karen Bush et al.   CLINICAL MICROBIOLOGY REVIEWS

Multidrug-Resistant Bacterial Infections in U.S. Hospitalized Patients, 2012–2017

(2020) John A. Jernigan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Needs assessment for novel Gram-negative antibiotics in US hospitals: a retrospective cohort study

(2020) Jeffrey R Strich et al.   LANCET INFECTIOUS DISEASES

International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti‐infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP)

(2019) Brian T. Tsuji et al.   PHARMACOTHERAPY

The Infectious Diseases Society of America’s 10 × ’20 Initiative (Ten New Systemic Antibacterial Agents FDA-approved by 2020): Is 20 × ’20 a Possibility?

(2019) George H Talbot et al.   CLINICAL INFECTIOUS DISEASES

Recognizing and Overcoming Resistance to New Beta-Lactam/Beta-Lactamase Inhibitor Combinations

(2019) Stephanie Ho et al.   Current Infectious Disease Reports

Molecular Epidemiology of Ceftriaxone-Nonsusceptible Enterobacterales Isolates in an Academic Medical Center in the United States

(2019) Pranita D Tamma et al.   Open Forum Infectious Diseases

Estimating the Treatment of Carbapenem-Resistant Enterobacteriaceae Infections in the United States Using Antibiotic Prescription Data

(2019) Cornelius J Clancy et al.   Open Forum Infectious Diseases

Charting the Path Forward Development, Goals and Initiatives of the 2019 IDSA Strategic Plan

(2019) Cynthia L Sears et al.   CLINICAL INFECTIOUS DISEASES

Effect of 5-Day Nitrofurantoin vs Single-Dose Fosfomycin on Clinical Resolution of Uncomplicated Lower Urinary Tract Infection in Women

(2018) Angela Huttner et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

A Systematic Review of Single-Dose Aminoglycoside Therapy for Urinary Tract Infection: Is It Time To Resurrect an Old Strategy?

(2018) Kellie J. Goodlet et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The ecology of extended-spectrum β-lactamases (ESBLs) in the developed world

(2017) Yohei Doi et al.   JOURNAL OF TRAVEL MEDICINE

Widespread Fosfomycin Resistance in Gram-Negative Bacteria Attributable to the Chromosomal fosA Gene

(2017) Ryota Ito et al.   mBio

Contemporary Diversity of β-Lactamases among Enterobacteriaceae in the Nine U.S. Census Regions and Ceftazidime-Avibactam Activity Tested against Isolates Producing the Most Prevalent β-Lactamase Groups

(2013) Mariana Castanheira et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

International Clinical Practice Guidelines for the Treatment of Acute Uncomplicated Cystitis and Pyelonephritis in Women: A 2010 Update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases

(2011) Kalpana Gupta et al.   CLINICAL INFECTIOUS DISEASES

Updated Functional Classification of  -Lactamases

(2009) K. Bush et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Unreliable Extended-Spectrum  -Lactamase Detection in the Presence of Plasmid-Mediated AmpC in Escherichia coli Clinical Isolates

(2008) F. J. L. Robberts et al.   JOURNAL OF CLINICAL MICROBIOLOGY